Cargando…
The Wnt Signaling Pathway Effector TCF7L2 Controls Gut and Brain Proglucagon Gene Expression and Glucose Homeostasis
The type 2 diabetes risk gene TCF7L2 is the effector of the Wnt signaling pathway. We found previously that in gut endocrine L-cell lines, TCF7L2 controls transcription of the proglucagon gene (gcg), which encodes the incretin hormone glucagon-like peptide-1 (GLP-1). Whereas peripheral GLP-1 stimula...
Autores principales: | Shao, Weijuan, Wang, Dingyan, Chiang, Yu-Ting, Ip, Wilfred, Zhu, Lingyun, Xu, Fenghao, Columbus, Joshua, Belsham, Denise D., Irwin, David M., Zhang, Haibo, Wen, Xiaoyan, Wang, Qinghua, Jin, Tianru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581223/ https://www.ncbi.nlm.nih.gov/pubmed/22966074 http://dx.doi.org/10.2337/db12-0365 |
Ejemplares similares
-
Activation of Intracellular Calcium by Multiple Wnt Ligands and Translocation of β-Catenin into the Nucleus: A CONVERGENT MODEL OF Wnt/Ca(2+) AND Wnt/β-CATENIN PATHWAYS
por: Thrasivoulou, Christopher, et al.
Publicado: (2013) -
A dock and coalesce mechanism driven by hydrophobic interactions governs Cdc42 binding with its effector protein ACK
por: Tetley, George J. N., et al.
Publicado: (2017) -
Small-Molecule Inhibitors of PKR Improve Glucose Homeostasis in Obese Diabetic Mice
por: Nakamura, Takahisa, et al.
Publicado: (2014) -
Protein Kinase PKN1 Represses Wnt/β-Catenin Signaling in Human Melanoma Cells
por: James, Richard G., et al.
Publicado: (2013) -
Examining Crosstalk among Transforming Growth Factor β, Bone Morphogenetic Protein, and Wnt Pathways
por: Coster, Adam D., et al.
Publicado: (2017)